Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil once daily versus PRN versus placebo after nerve-sparing prostatectomy
2004-002172-42Phase 4Completed
- Sponsor
- Bayer
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (3 arms), sponsored by Bayer. Primary endpoints: Primary efficacy endpoint, Erectile function after 9 months of treatment and 2 more. Started Nov 2004; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2004-002172-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002172-42.